Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis.
about
Update on Edoxaban for the Prevention and Treatment of Thromboembolism: Clinical Applications Based on Current EvidenceChoosing Non-Vitamin K Antagonist Oral Anticoagulants: Practical Considerations We Need to KnowEffectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort studyNon-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials.Individualising Anticoagulant Therapy in Atrial Fibrillation PatientsEffects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillationEdoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide.Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation.Drug Treatment of Venous Thromboembolism in the Elderly.Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro.Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study.Rationale and design of the RE-LATED AF--AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus--Effects of Dabigatran in patients with Atrial Fibrillation.Safety of percutaneous coronary intervention in patients with acute ischemic stroke/transient ischemic attack and acute coronary syndrome.Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation.Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre.Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation.
P2860
Q26782483-C826A386-E2FC-4663-9768-08FCDE84AB8BQ28074445-92C7D73F-33D9-4D90-B305-B8CA6A3AC1D6Q33647367-CC379439-B03A-4D1D-A12F-B804AAFA2B44Q34672746-E72B97E8-82B2-4BAD-A9DB-D6B38470D3D7Q37235927-36795A88-92DA-4564-A690-BA70FA8659BBQ37293260-28967EB6-2E2A-4610-95CB-DE439D0EF94EQ37699699-A4B9202E-F3F2-4276-9E95-9604A8812724Q38630768-BBE97B89-42E9-44AE-A2DE-44E060D847F9Q38647787-0A21EE86-A593-4F20-95B9-B3A210AE2354Q38683015-8B6A9680-0257-49C2-AF43-3298D1AF3C10Q38851927-919C58C0-1444-4C5E-B202-DFF05CE7508EQ39232066-5D94E95C-EF30-4CDE-BE94-780C4D658B0DQ40556805-8FAFEBA4-B817-4FBA-9710-979ED34E411EQ40799525-222A2B60-1914-4449-BC98-A448E0F77339Q41171327-EB30F766-C8C7-40A2-9C76-7FD9577D535DQ41307231-D3D9A457-47CF-46DC-9451-DEAE4CE59BF1Q41564940-3C069B1E-B1A8-4041-8820-656FECBAD2F0Q47365787-216DDC0E-C3FA-42A7-ABCA-A5FC9ECA6A36
P2860
Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Renal function and non-vitamin ...... and meta-regression analysis.
@en
type
label
Renal function and non-vitamin ...... and meta-regression analysis.
@en
prefLabel
Renal function and non-vitamin ...... and meta-regression analysis.
@en
P2860
P50
P921
P1476
Renal function and non-vitamin ...... and meta-regression analysis.
@en
P2093
Deirdre A Lane
P2860
P2888
P304
P356
10.1007/S00392-014-0797-9
P577
2014-11-22T00:00:00Z